Close Menu

Diagnostics Business News

Financial news, mergers and acquisitions, partnerships, and alliances.

After validating its pathogen detection platform for multiple viruses, the firm aims to initially offer a point-of-care diagnostic testing panel by the third quarter.

Predictive Technology said its 15-minute antibody test for COVID-19 has shown a 92 percent sensitivity and 100 percent specificity.

Atomo also said it has closed an oversubscribed initial public offering and that it intends to float its shares on the Australian Securities Exchange mid-month.

Credo Diagnostics recently received the CE mark for the coronavirus test, which can provide results in 20 minutes.

Under the agreement, the companies will combine Oxgene's Adenoviral Protein Machine technology with Native Antigen Company's antigens.